PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $476,000 | 0.0% | 161,998 | 0.0% | 0.02% | 0.0% |
Q1 2018 | $476,000 | -85.2% | 161,998 | -86.2% | 0.02% | -85.3% |
Q4 2017 | $3,222,000 | -17.4% | 1,175,779 | +2.2% | 0.12% | -18.9% |
Q3 2017 | $3,902,000 | +25.1% | 1,150,887 | -8.9% | 0.14% | +26.5% |
Q2 2017 | $3,120,000 | +15.3% | 1,262,960 | +5.9% | 0.11% | +17.7% |
Q1 2017 | $2,706,000 | -20.4% | 1,192,086 | +125.4% | 0.10% | +10.3% |
Q2 2015 | $3,400,000 | -13.2% | 528,809 | -5.1% | 0.09% | -12.1% |
Q1 2015 | $3,919,000 | -14.4% | 557,044 | -6.2% | 0.10% | +2.1% |
Q4 2014 | $4,576,000 | -9.5% | 593,614 | -12.3% | 0.10% | -4.0% |
Q3 2014 | $5,057,000 | -15.2% | 677,033 | +9.9% | 0.10% | -15.1% |
Q2 2014 | $5,965,000 | +229.6% | 616,155 | +182.9% | 0.12% | +183.3% |
Q1 2014 | $1,810,000 | +28.8% | 217,820 | +30.9% | 0.04% | +27.3% |
Q4 2013 | $1,405,000 | – | 166,450 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KESTREL INVESTMENT MANAGEMENT CORP | 1,465,000 | $3,853,000 | 1.56% |
SMH CAPITAL ADVISORS INC | 93,708 | $246,000 | 0.42% |
West Family Investments, Inc. | 627,800 | $1,651,000 | 0.39% |
KENNEDY CAPITAL MANAGEMENT LLC | 7,082,858 | $18,628,000 | 0.35% |
ARMISTICE CAPITAL, LLC | 1,800,000 | $4,734,000 | 0.28% |
BRANDES INVESTMENT PARTNERS, LP | 3,936,719 | $10,354,000 | 0.23% |
ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $38,000 | 0.13% |
Zebra Capital Management LLC | 74,695 | $196,000 | 0.09% |
Connor, Clark & Lunn Investment Management Ltd. | 5,968,105 | $15,696,000 | 0.09% |
CREDIT AGRICOLE S A | 471,644 | $1,240,000 | 0.06% |